Position in LXRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$318,963
-$24,019 QoQ
Shares Held
132,902
-39.6% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. LXRX ranks #299 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in LXRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $318,963 | 132,902 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $342,982 | 219,862 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $221,988 | 193,035 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $228,171 | 169,018 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $124,822 | 131,393 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $295,148 | 641,629 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $389,348 | 526,150 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $714,312 | 454,977 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $594,776 | 354,036 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $586,100 | 244,209 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,404,061 | 917,688 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $261,182 | 239,620 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $628,699 | 274,543 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $481,875 | 198,304 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $259,455 | 135,842 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $405,796 | 169,083 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,058,165 | 568,908 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $389,952 | 186,582 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $427,360 | 108,468 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $478,953 | 99,575 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $618,550 | 134,761 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $4,139,157 | 705,138 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,114,067 | 2,080,137 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,999,355 | 1,388,442 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,032,362 | 2,016,181 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $311,808 | 159,902 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||